Showing results (141-150 of 194) with videos related to
Sort By:
Pageof 20
Annals of the Rheumatic Diseases|January 17, 2024
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progressionSofia Pitsigavdaki, Myrto Nikoloudaki, Panagiotis Garantziotis, et al.JCI Insight|September 23, 2021
NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN-α production in patients with SLESpiros Georgakis, Katerina Gkirtzimanaki, Garyfalia Papadaki, et al.RMD Open|March 13, 2025
Transcriptome analysis to decipher the molecular underpinnings of response to treatment in systemic lupus erythematosusPanagiotis Garantziotis, Georgia Savina Moysidou, Noemin Kapsala, et al.The Journal of Rheumatology|April 3, 2018
Comparative Analysis and Predictors of 10-year Tumor Necrosis Factor Inhibitors Drug Survival in Patients with Spondyloarthritis: First-year Response Predicts Longterm Drug PersistenceIrini D Flouri, Theodora E Markatseli, Kyriaki A Boki, et al.Cell Metabolism|August 2, 2020
Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in AutoimmunityThemis Alissafi, Lydia Kalafati, Maria Lazari, et al.Cancer Immunology Research|April 6, 2021
Regulatory T-cell Transcriptomic Reprogramming Characterizes Adverse Events by Checkpoint Inhibitors in Solid TumorsMaria Grigoriou, Aggelos Banos, Aikaterini Hatzioannou, et al.Annals of the Rheumatic Diseases|May 10, 2025
Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosusDionysis Nikolopoulos, George Sentis, Iasonas Kitsios, et al.Annals of the Rheumatic Diseases|September 15, 2011
A common SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesisVassilios M Vazgiourakis, Maria I Zervou, Christianna Choulaki, et al.Lupus Science & Medicine|May 27, 2026
Beyond renal response: sustained systemic disease control protects against adverse long-term outcomes in lupus nephritisKonstantinos Drougkas, Spyridon Katechis, Myrto Kostopoulou, et al.Journal of Autoimmunity|January 22, 2026
Molecular stratification and transcriptome-guided therapeutics in systemic lupus erythematosus with insufficient treatment responseLorenzo Beretta, Chiu Wai Shirley Chan, Georgia-Savina Moysidou, et al.Pageof 20